ConvaTec Group (LON:CTEC) Reaches New 52-Week High at $293.60

Shares of ConvaTec Group PLC (LON:CTEC) reached a new 52-week high on Thursday . The stock traded as high as GBX 293.60 ($3.71) and last traded at GBX 289.20 ($3.65), with a volume of 5216740 shares. The stock had previously closed at GBX 289.60 ($3.66).

Wall Street Analyst Weigh In

CTEC has been the subject of several research reports. JPMorgan Chase & Co. increased their price target on ConvaTec Group from GBX 300 ($3.79) to GBX 323 ($4.08) and gave the stock an “overweight” rating in a research note on Thursday, March 7th. Berenberg Bank raised their target price on ConvaTec Group from GBX 290 ($3.66) to GBX 310 ($3.92) and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat, ConvaTec Group currently has an average rating of “Buy” and an average target price of GBX 307.17 ($3.88).

ConvaTec Group Stock Down 0.7 %

The company has a market cap of £5.89 billion, a P/E ratio of 5,784.00, a P/E/G ratio of 2.59 and a beta of 0.55. The stock has a 50-day moving average of GBX 256.26 and a two-hundred day moving average of GBX 235.15. The company has a debt-to-equity ratio of 77.59, a quick ratio of 0.96 and a current ratio of 1.62.

ConvaTec Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Thursday, May 23rd. Shareholders of record on Thursday, April 25th will be paid a dividend of $0.04 per share. The ex-dividend date is Thursday, April 25th. This is an increase from ConvaTec Group’s previous dividend of $0.02. This represents a dividend yield of 1.39%. ConvaTec Group’s dividend payout ratio (DPR) is 10,000.00%.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacture, and marketing of medical products and technologies worldwide. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.